Bicycle Therapeutics Plc (BCYC)
4.52
+0.18
(+4.15%)
USD |
NASDAQ |
Mar 24, 15:52
Bicycle Therapeutics Shareholders Equity (Quarterly) : 609.98M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | 40.92M |
| Autolus Therapeutics Plc | 265.45M |
| DBV Technologies SA | 52.85M |
| Cellectis SA | 75.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 717.60M |
| Total Liabilities (Quarterly) | 107.62M |
| Debt to Equity Ratio | 0.0287 |
| Current Ratio | 11.98 |
| Net Debt Paydown Yield | -0.26% |